| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |